Prometrium Cost in North Dakota 2026: Cash Price, Insurance, and Compounded Options

What Does Prometrium Actually Cost in North Dakota in 2026?

Prometrium's sticker price and what a patient actually pays are very different numbers. The AbbVie/Solvay manufacturer list price sits near $180 for a 30-day supply in 2026. Cash-paying patients at North Dakota retail pharmacies typically pay around $45 per month once GoodRx-style coupons or pharmacy discount programs are applied. Patients with commercial insurance who clear their deductible often pay a $30 to $60 co-pay, depending on their formulary tier.

Retail Pharmacy Cash Prices Across North Dakota

Prices vary by city and by pharmacy chain. Bismarck, Fargo, Grand Forks, and Minot all have major retail chains, including CVS, Walgreens, and Walmart Pharmacy, as well as independent pharmacies that may price differently. Walmart's $4/$10 generic list does not include Prometrium, because Prometrium remains a brand-name product with no FDA-approved generic equivalent as of 2026.

Calling ahead with a GoodRx or RxSaver coupon code before pickup routinely brings the cash price to the $40 to $50 range. The FDA maintains that Prometrium is the reference listed drug for oral micronized progesterone capsules, meaning any generic would require its own bioequivalence data. No such generic has received FDA approval.

Why the List Price Is So High

AbbVie acquired Solvay Pharmaceuticals in 2010, absorbing the Prometrium brand. Brand-name drugs without generic competition face minimal pricing pressure. The Women's Health Initiative and the PEPI trial (N=875) both used oral micronized progesterone as the progestogen comparator, giving the compound a strong evidence base, but that evidence does not translate to a lower list price. PEPI (JAMA 1995) showed that oral micronized progesterone combined with conjugated estrogen produced more favorable HDL cholesterol effects than synthetic progestins like medroxyprogesterone acetate.

The HealthRX clinical team uses a three-tier cost-access framework for progesterone prescribing in states without Medicaid HRT coverage: (1) brand Prometrium with manufacturer savings card, (2) retail cash-pay with coupon, and (3) compounded micronized progesterone from a licensed 503A pharmacy. North Dakota patients can access all three tiers.

Does North Dakota Medicaid Cover Prometrium?

North Dakota Medicaid does not cover Prometrium for endometrial protection as part of hormone replacement therapy. This is consistent with how many state Medicaid programs approach HRT: coverage is often limited to specific indications such as premature ovarian insufficiency or surgical menopause before age 40, and formulary restrictions exclude brand-name products when a therapeutic alternative exists.

What North Dakota Medicaid Does Cover

North Dakota Medicaid may cover medroxyprogesterone acetate (Provera) as a lower-cost progestogen option. Patients on Medicaid who need progestogen protection of the endometrium should ask their prescriber whether medroxyprogesterone acetate is an acceptable alternative given their clinical history.

The 2022 Menopause Society (formerly NAMS) position statement notes that micronized progesterone is associated with a more favorable breast safety profile compared with synthetic progestins, citing data from the French E3N cohort (N=80,377). For patients who prefer micronized progesterone specifically, the compounded 503A route at approximately $25 per month is the most affordable path when Medicaid declines coverage.

Appealing a Medicaid Denial

A prescriber can submit a prior authorization request arguing medical necessity. Grounds might include a documented adverse reaction to medroxyprogesterone acetate, a psychiatric history that worsens with synthetic progestins, or a patient preference backed by the E3N cohort data showing lower breast cancer risk. The NIH's MedlinePlus resource on progesterone describes the approved indications that may support a prior authorization argument.

Approvals are rare but not impossible. Keep records of any adverse effects from alternative progestogens.

Is Compounded Micronized Progesterone Legal in North Dakota?

Yes. Compounded micronized progesterone is legal in North Dakota when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies; they must compound based on individual prescriptions and cannot produce large batches for office stock.

How 503A Compounding Works in North Dakota

North Dakota's State Board of Pharmacy licenses and inspects compounding pharmacies under state pharmacy practice law aligned with USP <795> (non-sterile preparations) standards. A prescriber writes a prescription for micronized progesterone specifying strength, dose form (typically an oral capsule), and quantity. The pharmacy compounds the capsules from pharmaceutical-grade progesterone powder. USP standards for compounding are maintained by the FDA's compounding guidance pages.

Patients should verify that their chosen compounding pharmacy holds an active North Dakota license before filling. Shipping from an out-of-state 503A pharmacy is permissible if that pharmacy is also licensed to dispense into North Dakota.

Cost Advantage of Compounded Progesterone

At roughly $25 per month, compounded micronized progesterone costs about 44% less than the average retail cash price for brand Prometrium. Over 12 months, that gap is approximately $240. The clinical difference is that compounded preparations are not FDA-approved for potency, sterility, or stability to the same standard as Prometrium, though reputable 503A pharmacies perform internal quality testing.

The FDA's guidance on 503A compounding distinguishes between 503A pharmacies (patient-specific prescriptions) and 503B outsourcing facilities (larger-scale, FDA-registered). Most retail compounders in North Dakota operate under 503A.

What to Ask Your Compounding Pharmacy

Ask for a certificate of analysis on the progesterone raw material. Ask whether the pharmacy conducts beyond-use date testing. The FDA's current good compounding practice guidance outlines what well-run compounding pharmacies should be doing. A pharmacy unwilling to share quality documentation is a red flag.

Prometrium Insurance Coverage in North Dakota

Commercial insurance coverage for Prometrium in North Dakota depends entirely on the specific plan formulary. Large employers in the state, including those in agriculture, energy, and healthcare sectors, typically offer plans through national PBMs such as Express Scripts, OptumRx, or CVS Caremark. Each PBM's formulary places Prometrium at a different tier.

Tier Placement and What It Means for Your Co-Pay

• Tier 1 (preferred generic): Prometrium is rarely placed here because it has no generic.
• Tier 2 (preferred brand): Some plans list Prometrium at this level, with co-pays in the $30 to $60 range per 30-day supply.
• Tier 3 (non-preferred brand): Co-pays of $60 to $100 are common.
• Tier 4 or specialty: Unusual for Prometrium, but possible on narrow formularies.

Before filling, call the member services number on your insurance card and ask for the formulary tier for NDC 00032-1708-01 (Prometrium 100 mg) or NDC 00032-1710-01 (Prometrium 200 mg). If placed at Tier 3 or higher, ask whether a step-therapy exception is available if you have tried and failed a lower-tier progestogen.

ACA Marketplace Plans in North Dakota

North Dakota residents using the federal marketplace (healthcare.gov) can compare Silver and Gold tier plans. Preventive services under ACA Section 2713 must be covered without cost-sharing when an A or B USPSTF recommendation applies. The USPSTF does not give hormone therapy for menopause an A or B recommendation for chronic disease prevention as of 2025, which means insurers are not required to cover Prometrium without cost-sharing under the preventive mandate. Coverage remains at the plan's discretion.

Employer-Sponsored Plans and Prior Authorization

Many employer-sponsored North Dakota plans require prior authorization for Prometrium. Common PA criteria include a confirmed diagnosis of menopause (ICD-10 N95.1), documentation that the drug is prescribed for endometrial protection in a woman with a uterus on estrogen therapy, and sometimes a trial of a lower-tier progestogen. Your prescriber's office can submit the PA form; turnaround is typically 3 to 5 business days.

The FDA-approved Prometrium prescribing information specifies the approved indications, which your insurer will reference during the PA review.

How the AbbVie/Solvay Savings Card Works in North Dakota

AbbVie offers a Prometrium savings card for commercially insured patients. The card is not valid for patients on Medicaid, Medicare, or any government-funded insurance program. In North Dakota, Medicaid patients are excluded by program rules; Medicare Part D patients are also excluded under the federal anti-kickback carve-out.

Eligible Patients: What the Card Covers

Commercially insured North Dakota patients can enroll at the Prometrium savings card website. The card reduces out-of-pocket cost to as low as $25 per fill for eligible patients, with a maximum annual benefit typically capped at $150 or $200 per month in savings. Read the fine print: the savings cap resets annually, and some plans' co-pay accumulator programs may prevent the card's payments from counting toward your deductible.

Co-Pay Accumulators and North Dakota Plans

Co-pay accumulator adjustment programs are common in North Dakota employer plans and marketplace plans. Under these programs, the dollars paid by the manufacturer savings card do not count toward your annual deductible or out-of-pocket maximum. This means you may exhaust the savings card benefit mid-year and then face full out-of-pocket costs until your deductible is met. The American Journal of Managed Care has documented how accumulators affect patient affordability for brand-name drugs.

Ask your HR benefits team or plan administrator explicitly whether co-pay accumulators apply before relying on the savings card as your primary cost-management strategy.

Can You Get Prometrium via Telehealth in North Dakota?

Yes. Telehealth prescribing of Prometrium is permitted in North Dakota. A licensed physician, nurse practitioner, or physician assistant can conduct a synchronous video visit and issue a valid prescription for Prometrium or compounded micronized progesterone to a North Dakota patient.

State Telehealth Rules for Controlled Substances

Progesterone is not a controlled substance under the DEA Schedules, so none of the Ryan Haight Act restrictions that apply to medications like testosterone or benzodiazepines apply here. A prescriber can establish a patient-provider relationship via video and prescribe Prometrium without an in-person visit first. North Dakota Century Code Chapter 43-17.1 governs telehealth practice and requires real-time two-way audio-visual communication for the initial prescribing encounter in most cases.

HealthRX Telehealth Process for North Dakota Patients

Patients in Bismarck, Fargo, Grand Forks, Minot, Williston, and rural areas across North Dakota can initiate a telehealth visit, receive a Prometrium prescription electronically, and have it sent to any North Dakota retail pharmacy or a licensed compounding pharmacy. Turnaround from visit to prescription sent is typically same-day. Lab work (serum estradiol, progesterone, FSH, and a current pap smear or OB-GYN visit within 12 months) is reviewed before prescribing.

Evidence Supporting Telehealth for Menopause Management

A 2021 study published in Menopause (the journal of the Menopause Society) found that telehealth menopause consultations produced adherence rates comparable to in-person visits for HRT initiation. The Menopause Society's position on telehealth prescribing of HRT supports its use for appropriate candidates, noting that video-based assessment can adequately capture the clinical information needed for safe prescribing.

Clinical Background: Why Micronized Progesterone Is Prescribed

Prometrium contains micronized progesterone, a bioidentical form of the hormone produced by the corpus luteum and placenta. Women with a uterus who take systemic estrogen for menopausal symptoms require concurrent progestogen therapy to protect the endometrial lining from unopposed estrogen-driven hyperplasia. The FDA-approved label for Prometrium specifies two indications: endometrial protection in postmenopausal women receiving conjugated estrogen, and secondary amenorrhea.

PEPI Trial Data and Cardiovascular Effects

The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial (N=875, JAMA 1995) is the landmark randomized controlled trial comparing different progestogen regimens. PEPI found that oral micronized progesterone combined with conjugated estrogen 0.625 mg preserved HDL cholesterol more effectively than conjugated estrogen combined with medroxyprogesterone acetate. HDL increased by 1.6 mg/dL in the CEE plus MPA arm versus 4.1 mg/dL in the CEE plus micronized progesterone arm at three years.

This favorable lipid profile has contributed to clinician preference for micronized progesterone in women with cardiovascular risk factors, though the Women's Health Initiative did not directly compare the two progestogens head-to-head.

Breast Safety Data from the E3N Cohort

The French E3N prospective cohort (N=80,377) published in Breast Cancer Research and Treatment found that combined estrogen plus micronized progesterone did not increase breast cancer risk over 8.1 years of follow-up, in contrast to combined estrogen plus synthetic progestins. The E3N cohort study reported a relative risk of 1.00 (95% CI 0.83 to 1.22) for estrogen plus micronized progesterone, compared with 1.69 (95% CI 1.50 to 1.91) for estrogen plus synthetic progestins.

This data point is frequently cited when prescribers choose Prometrium over medroxyprogesterone acetate for long-term HRT users.

Standard Dosing Regimens

Two regimens are commonly prescribed. The sequential regimen uses 200 mg nightly for 12 consecutive days of a 28-day cycle, producing a monthly withdrawal bleed. The continuous regimen uses 100 mg nightly every day, which over time produces amenorrhea in most women. The Menopause Society's 2022 position statement describes both regimens as evidence-supported options for endometrial protection.

Drowsiness is the most commonly reported side effect, which is why bedtime dosing is standard. A 2014 pharmacokinetic analysis published in Steroids confirmed that peak serum progesterone levels after oral micronized progesterone occur approximately 3 hours after ingestion, consistent with bedtime dosing to minimize daytime sedation.

What's the Cheapest Way to Get Prometrium in North Dakota?

The lowest total monthly cost for most North Dakota patients in 2026 is compounded micronized progesterone from a licensed 503A pharmacy at approximately $25 per month. For patients who require the FDA-approved brand product, applying a GoodRx coupon at a retail pharmacy brings the cost to the $40 to $50 range. Commercially insured patients with Tier 2 formulary placement plus the AbbVie savings card (and no co-pay accumulator) may pay $25 per fill.

Cost Comparison Table

| Option | Approx. Monthly Cost | Notes | |---|---|---| | Manufacturer list price (brand Prometrium) | $180 | No coupons applied | | Retail cash price with GoodRx/RxSaver | $45 | North Dakota average 2026 | | Commercial insurance Tier 2 co-pay | $30 to $60 | Plan-dependent | | AbbVie savings card (eligible patients) | As low as $25 | Commercial insurance only; accumulators may apply | | Compounded micronized progesterone (503A) | $25 | Patient-specific Rx required; not FDA-approved | | North Dakota Medicaid | Not covered | For HRT endometrial protection indication |

GoodRx and Other Coupon Platforms

GoodRx, RxSaver, and NeedyMeds all aggregate pharmacy-level pricing. These platforms work by negotiating pre-set rates with pharmacy benefit processors. They are not insurance. Using a coupon at the pharmacy counter means you pay the coupon rate, not your insurance co-pay, and the amount typically does not count toward your deductible. The FDA's consumer information page on drug pricing outlines the field of discount programs.

For North Dakota patients with high-deductible plans who have not yet met their deductible, the GoodRx or RxSaver cash price of roughly $45 per month beats most insurance-billed rates until the deductible clears.